Paris-based Omnidoc, a tele-expertise and e-RCP solutions provider for healthcare professionals and medical organisations, has secured €6M in a new funding round.
The round was led by Alven, with support from existing investors Kurma and Newfund.
The company plans to use the funds to expand its operations in France and internationally. Omnidoc aims to establish itself as a leading platform for medical collaboration, enhancing the way healthcare professionals connect and share expertise.
A platform that facilitates and enhances medical collaboration
Omnidoc is a tele-expertise platform that facilitates secure and efficient exchanges of medical opinions between doctors, enabling easier access to specialist advice, faster diagnoses, and optimised treatment.
The company also helps to streamline patient care by improving the tracking, traceability, and financial valuation of medical exchanges.
Deployed in 50 per cent of French public hospitals, the platform supports over a million tele-expertise consultations annually, contributing to more efficient healthcare delivery amid a medical workforce shortage.
The company was launched in 2019 and claims that its platform has become widely adopted in France, with its solution now used by 60 per cent of University Hospital Centers (CHU) and over 80,000 healthcare professionals.
Capital utilisation
The funds will help Omnidoc to enhance its services further. The company intends to recruit 20 additional staff members to strengthen its engineering and support teams.
Omnidoc also aims to expand its platform’s capabilities beyond tele-expertise, developing new features such as multidisciplinary concertation meetings, assisted teleconsultation, emergency management, and inter-institutional services.
The company aims to connect various healthcare players—hospitals, specialists, clinics, and primary care organisations—to streamline communication and optimise patient care pathways.
Expansion in 2025
Omnidoc’s new financing will help fuel its international expansion, building on its initial roll-out in Belgium last October at the Brugmann and Saint-Pierre teaching hospitals in Brussels.
The company plans to accelerate its growth in Belgium and expand into Germany by 2025. This expansion aims to address the increasing demand for medical collaboration in European markets, which are facing similar healthcare challenges.
01
From port to startup fort: How Lars Crama is ‘Making it Happen’ in Rotterdam